$NXGN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in NEXTGEN HEALTHCARE, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in NEXTGEN HEALTHCARE, INC.. Get notifications about new insider transactions in NEXTGEN HEALTHCARE, INC. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 29 2021 | NXGN | NEXTGEN HEALTHCARE ... | Arnold James Robert Jr. | Chief Financial Off ... | Payment of Exercise | F | 16.69 | 2,946 | 49,169 | 377,121 | 380.1 K to 377.1 K (-0.78 %) |
Apr 26 2021 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 18.84 | 12,022 | 226,494 | 426,306 | 438.3 K to 426.3 K (-2.74 %) |
Apr 13 2021 | NXGN | NEXTGEN HEALTHCARE ... | Barbarosh Craig A. | Director | Sell | S | 18.70 | 9,000 | 168,342 | 90,946 | 99.9 K to 90.9 K (-9.00 %) |
Mar 23 2021 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Sell | S | 18.99 | 25,000 | 474,845 | 438,328 | 463.3 K to 438.3 K (-5.40 %) |
Feb 09 2021 | NXGN | NEXTGEN HEALTHCARE ... | Rosenzweig Lance | Director | Sell | S | 20.88 | 6,000 | 125,302 | 35,782 | 41.8 K to 35.8 K (-14.36 %) |
Feb 09 2021 | NXGN | NEXTGEN HEALTHCARE ... | Rosenzweig Lance | Director | Sell | S | 20.77 | 6,000 | 124,602 | 41,782 | 47.8 K to 41.8 K (-12.56 %) |
Feb 09 2021 | NXGN | NEXTGEN HEALTHCARE ... | Rosenzweig Lance | Director | Sell | S | 20.52 | 12,000 | 246,235 | 47,782 | 59.8 K to 47.8 K (-20.07 %) |
Feb 05 2021 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Sell | S | 19.81 | 25,000 | 495,348 | 463,328 | 488.3 K to 463.3 K (-5.12 %) |
Feb 04 2021 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Option Exercise | M | 16.83 | 3,000 | 50,490 | 6,000 | |
Feb 04 2021 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Option Exercise | M | 16.64 | 1,500 | 24,960 | 0 | |
Feb 04 2021 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Option Exercise | M | 16.37 | 3,250 | 53,203 | 3,250 | |
Feb 04 2021 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Sell | S | 19.61 | 10,446 | 204,869 | 31,006 | 41.5 K to 31 K (-25.20 %) |
Feb 04 2021 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Buy | M | 16.83 | 3,000 | 50,490 | 41,452 | 38.5 K to 41.5 K (+7.80 %) |
Feb 04 2021 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Buy | M | 16.64 | 1,500 | 24,960 | 38,452 | 37 K to 38.5 K (+4.06 %) |
Feb 04 2021 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Buy | M | 16.37 | 3,250 | 53,203 | 36,952 | 33.7 K to 37 K (+9.64 %) |
Dec 30 2020 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 18.19 | 10,498 | 190,959 | 488,328 | 498.8 K to 488.3 K (-2.10 %) |
Dec 30 2020 | NXGN | NEXTGEN HEALTHCARE ... | Arnold James Robert Jr. | Chief Financial Off ... | Payment of Exercise | F | 18.19 | 7,829 | 142,410 | 378,759 | 386.6 K to 378.8 K (-2.03 %) |
Dec 30 2020 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Payment of Exercise | F | 18.19 | 6,403 | 116,471 | 135,717 | 142.1 K to 135.7 K (-4.51 %) |
Dec 29 2020 | NXGN | NEXTGEN HEALTHCARE ... | Arnold James Robert Jr. | Chief Financial Off ... | Payment of Exercise | F | 18.44 | 4,142 | 76,378 | 386,588 | 390.7 K to 386.6 K (-1.06 %) |
Dec 29 2020 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Payment of Exercise | F | 18.44 | 3,937 | 72,598 | 142,120 | 146.1 K to 142.1 K (-2.70 %) |
Dec 29 2020 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 18.44 | 17,533 | 323,309 | 498,826 | 516.4 K to 498.8 K (-3.40 %) |
Dec 29 2020 | NXGN | NEXTGEN HEALTHCARE ... | LINTON JEFFREY D | EVP, General Counse ... | Payment of Exercise | F | 18.44 | 2,548 | 46,985 | 69,848 | 72.4 K to 69.8 K (-3.52 %) |
Dec 23 2020 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Sell | S | 17.85 | 50,000 | 892,665 | 516,359 | 566.4 K to 516.4 K (-8.83 %) |
Dec 07 2020 | NXGN | NEXTGEN HEALTHCARE ... | Bristol George H | Director | Sell | S | 17.50 | 7,000 | 122,500 | 51,861 | 58.9 K to 51.9 K (-11.89 %) |
Dec 07 2020 | NXGN | NEXTGEN HEALTHCARE ... | Bristol George H | Director | Sell | S | 17.50 | 8,200 | 143,511 | 58,861 | 67.1 K to 58.9 K (-12.23 %) |
Dec 07 2020 | NXGN | NEXTGEN HEALTHCARE ... | Bristol George H | Director | Sell | S | 17.52 | 4,800 | 84,091 | 67,061 | 71.9 K to 67.1 K (-6.68 %) |
Oct 28 2020 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Grant | A | 0.00 | 4,000 | 0 | 33,643 | 29.6 K to 33.6 K (+13.49 %) |
Oct 28 2020 | NXGN | NEXTGEN HEALTHCARE ... | Arnold James Robert Jr. | Chief Financial Off ... | Option Exercise | A | 0.00 | 90,000 | 0 | 185,203 | |
Oct 28 2020 | NXGN | NEXTGEN HEALTHCARE ... | Arnold James Robert Jr. | Chief Financial Off ... | Grant | A | 0.00 | 60,000 | 0 | 390,730 | 330.7 K to 390.7 K (+18.14 %) |
Oct 28 2020 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Option Exercise | A | 0.00 | 55,287 | 0 | 128,434 | |
Oct 28 2020 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Grant | A | 0.00 | 36,858 | 0 | 146,057 | 109.2 K to 146.1 K (+33.75 %) |
Oct 28 2020 | NXGN | NEXTGEN HEALTHCARE ... | LINTON JEFFREY D | EVP, General Counse ... | Option Exercise | A | 0.00 | 33,429 | 0 | 77,741 | |
Oct 28 2020 | NXGN | NEXTGEN HEALTHCARE ... | LINTON JEFFREY D | EVP, General Counse ... | Grant | A | 0.00 | 22,286 | 0 | 72,153 | 49.9 K to 72.2 K (+44.69 %) |
Oct 28 2020 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Option Exercise | A | 0.00 | 167,143 | 0 | 388,302 | |
Oct 28 2020 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Grant | A | 0.00 | 111,429 | 0 | 566,359 | 454.9 K to 566.4 K (+24.49 %) |
Oct 26 2020 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Payment of Exercise | F | 15.01 | 4,090 | 61,391 | 109,199 | 113.3 K to 109.2 K (-3.61 %) |
Oct 26 2020 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Payment of Exercise | F | 15.01 | 4,090 | 61,391 | 109,199 | 113.3 K to 109.2 K (-3.61 %) |
Oct 26 2020 | NXGN | NEXTGEN HEALTHCARE ... | LINTON JEFFREY D | EVP, General Counse ... | Payment of Exercise | F | 15.01 | 2,478 | 37,195 | 49,693 | 52.2 K to 49.7 K (-4.75 %) |
Oct 26 2020 | NXGN | NEXTGEN HEALTHCARE ... | LINTON JEFFREY D | EVP, General Counse ... | Payment of Exercise | F | 15.01 | 2,478 | 37,195 | 49,693 | 52.2 K to 49.7 K (-4.75 %) |
Oct 26 2020 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 15.01 | 12,158 | 182,492 | 454,930 | 467.1 K to 454.9 K (-2.60 %) |
Oct 26 2020 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 15.01 | 12,158 | 182,492 | 454,930 | 467.1 K to 454.9 K (-2.60 %) |
Aug 19 2020 | NXGN | NEXTGEN HEALTHCARE ... | Rosenzweig Lance | Director | Grant | A | 0.00 | 11,837 | 0 | 59,782 | 47.9 K to 59.8 K (+24.69 %) |
Aug 19 2020 | NXGN | NEXTGEN HEALTHCARE ... | Rosenzweig Lance | Director | Grant | A | 0.00 | 11,837 | 0 | 59,782 | 47.9 K to 59.8 K (+24.69 %) |
Aug 19 2020 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Grant | A | 0.00 | 14,706 | 0 | 9,889,827 | 9.9 M to 9.9 M (+0.15 %) |
Aug 19 2020 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Grant | A | 0.00 | 14,706 | 0 | 9,889,827 | 9.9 M to 9.9 M (+0.15 %) |
Aug 19 2020 | NXGN | NEXTGEN HEALTHCARE ... | PANNER MORRIS | Director | Grant | A | 0.00 | 11,837 | 0 | 69,015 | 57.2 K to 69 K (+20.70 %) |
Aug 19 2020 | NXGN | NEXTGEN HEALTHCARE ... | MARGOLIS JEFFREY H | Director | Grant | A | 0.00 | 14,706 | 0 | 110,810 | 96.1 K to 110.8 K (+15.30 %) |
Aug 19 2020 | NXGN | NEXTGEN HEALTHCARE ... | MALONE JAMES C | Director | Grant | A | 0.00 | 11,837 | 0 | 70,490 | 58.7 K to 70.5 K (+20.18 %) |
Aug 19 2020 | NXGN | NEXTGEN HEALTHCARE ... | Klapstein Julie D | Director | Grant | A | 0.00 | 11,837 | 0 | 39,076 | 27.2 K to 39.1 K (+43.46 %) |
Aug 19 2020 | NXGN | NEXTGEN HEALTHCARE ... | Bristol George H | Director | Grant | A | 0.00 | 11,837 | 0 | 71,861 | 60 K to 71.9 K (+19.72 %) |
Aug 19 2020 | NXGN | NEXTGEN HEALTHCARE ... | Barbarosh Craig A. | Director | Grant | A | 0.00 | 14,706 | 0 | 99,946 | 85.2 K to 99.9 K (+17.25 %) |
Aug 12 2020 | NXGN | NEXTGEN HEALTHCARE ... | Rosenzweig Lance | Director | Sell | S | 14.54 | 1,764 | 25,647 | 47,945 | 49.7 K to 47.9 K (-3.55 %) |
Aug 11 2020 | NXGN | NEXTGEN HEALTHCARE ... | Rosenzweig Lance | Director | Sell | S | 14.60 | 5,687 | 83,039 | 49,709 | 55.4 K to 49.7 K (-10.27 %) |
Aug 11 2020 | NXGN | NEXTGEN HEALTHCARE ... | Rosenzweig Lance | Director | Sell | S | 14.60 | 5,687 | 83,039 | 49,709 | 55.4 K to 49.7 K (-10.27 %) |
Aug 10 2020 | NXGN | NEXTGEN HEALTHCARE ... | Rosenzweig Lance | Director | Sell | S | 14.73 | 5,700 | 83,966 | 55,396 | 61.1 K to 55.4 K (-9.33 %) |
Jun 30 2020 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Payment of Exercise | F | 10.19 | 4,250 | 43,308 | 113,289 | 117.5 K to 113.3 K (-3.62 %) |
Jun 30 2020 | NXGN | NEXTGEN HEALTHCARE ... | LINTON JEFFREY D | EVP, General Counse ... | Payment of Exercise | F | 10.19 | 1,919 | 19,555 | 52,171 | 54.1 K to 52.2 K (-3.55 %) |
Jun 30 2020 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 10.19 | 15,634 | 159,310 | 467,088 | 482.7 K to 467.1 K (-3.24 %) |
Jun 16 2020 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Payment of Exercise | F | 10.25 | 674 | 6,909 | 20,043 | 20.7 K to 20 K (-3.25 %) |
Jun 03 2020 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Payment of Exercise | F | 10.29 | 817 | 8,407 | 20,717 | 21.5 K to 20.7 K (-3.79 %) |
Jun 03 2020 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Payment of Exercise | F | 10.29 | 361 | 3,715 | 21,534 | 21.9 K to 21.5 K (-1.65 %) |
Jun 03 2020 | NXGN | NEXTGEN HEALTHCARE ... | Ahmadzai David | Chief Accounting Of ... | Grant | A | 0.00 | 8,000 | 0 | 21,895 | 13.9 K to 21.9 K (+57.57 %) |
Apr 24 2020 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 10.37 | 11,683 | 121,153 | 482,722 | 494.4 K to 482.7 K (-2.36 %) |
Mar 13 2020 | NXGN | NEXTGEN HEALTHCARE ... | Arnold James Robert Jr. | Chief Financial Off ... | Buy | P | 9.20 | 5,000 | 46,000 | 328,766 | 323.8 K to 328.8 K (+1.54 %) |
Jan 28 2020 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Option Exercise | A | 0.00 | 119,559 | 0 | 221,159 | |
Jan 28 2020 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Grant | A | 0.00 | 236,230 | 0 | 494,405 | 258.2 K to 494.4 K (+91.50 %) |
Dec 30 2019 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 15.86 | 10,524 | 166,900 | 258,175 | 268.7 K to 258.2 K (-3.92 %) |
Dec 30 2019 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Payment of Exercise | F | 15.86 | 6,403 | 101,545 | 117,539 | 123.9 K to 117.5 K (-5.17 %) |
Dec 30 2019 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 15.86 | 10,524 | 166,900 | 258,175 | 268.7 K to 258.2 K (-3.92 %) |
Dec 30 2019 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Payment of Exercise | F | 15.86 | 6,403 | 101,545 | 117,539 | 123.9 K to 117.5 K (-5.17 %) |
Dec 30 2019 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Option Exercise | A | 0.00 | 39,547 | 0 | 73,147 | |
Dec 30 2019 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Grant | A | 0.00 | 51,442 | 0 | 123,942 | 72.5 K to 123.9 K (+70.95 %) |
Dec 30 2019 | NXGN | NEXTGEN HEALTHCARE ... | LINTON JEFFREY D | EVP, General Counse ... | Option Exercise | A | 0.00 | 23,912 | 0 | 44,312 | |
Dec 30 2019 | NXGN | NEXTGEN HEALTHCARE ... | LINTON JEFFREY D | EVP, General Counse ... | Grant | A | 0.00 | 33,293 | 0 | 52,721 | 19.4 K to 52.7 K (+171.37 %) |
Dec 30 2019 | NXGN | NEXTGEN HEALTHCARE ... | Arnold James Robert Jr. | Chief Financial Off ... | Option Exercise | A | 0.00 | 51,503 | 0 | 95,203 | |
Dec 30 2019 | NXGN | NEXTGEN HEALTHCARE ... | Arnold James Robert Jr. | Chief Financial Off ... | Grant | A | 0.00 | 65,360 | 0 | 323,766 | 258.4 K to 323.8 K (+25.29 %) |
Dec 16 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Gift | G | 0.00 | 278,000 | 0 | 9,875,121 | 10.2 M to 9.9 M (-2.74 %) |
Oct 24 2019 | NXGN | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Payment of Exercise | F | 15.94 | 2,847 | 45,381 | 72,500 | 75.3 K to 72.5 K (-3.78 %) |
Oct 24 2019 | NXGN | NEXTGEN HEALTHCARE ... | LINTON JEFFREY D | EVP, General Counse ... | Payment of Exercise | F | 15.94 | 1,729 | 27,560 | 19,150 | 20.9 K to 19.2 K (-8.28 %) |
Oct 24 2019 | NXGN | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 15.94 | 11,238 | 179,134 | 268,699 | 279.9 K to 268.7 K (-4.01 %) |
Aug 16 2019 | NXGN | NEXTGEN HEALTHCARE ... | Rosenzweig Lance | Director | Grant | A | 0.00 | 11,419 | 0 | 61,096 | 49.7 K to 61.1 K (+22.99 %) |
Aug 16 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Grant | A | 0.00 | 14,187 | 0 | 10,153,121 | 10.1 M to 10.2 M (+0.14 %) |
Aug 16 2019 | NXGN | NEXTGEN HEALTHCARE ... | PANNER MORRIS | Director | Grant | A | 0.00 | 11,419 | 0 | 57,178 | 45.8 K to 57.2 K (+24.95 %) |
Aug 16 2019 | NXGN | NEXTGEN HEALTHCARE ... | MARGOLIS JEFFREY H | Director | Grant | A | 0.00 | 14,187 | 0 | 86,104 | 71.9 K to 86.1 K (+19.73 %) |
Aug 16 2019 | NXGN | NEXTGEN HEALTHCARE ... | MALONE JAMES C | Director | Grant | A | 0.00 | 11,419 | 0 | 58,653 | 47.2 K to 58.7 K (+24.18 %) |
Aug 16 2019 | NXGN | NEXTGEN HEALTHCARE ... | Klapstein Julie D | Director | Grant | A | 0.00 | 11,419 | 0 | 27,239 | 15.8 K to 27.2 K (+72.18 %) |
Aug 16 2019 | NXGN | NEXTGEN HEALTHCARE ... | Bristol George H | Director | Grant | A | 0.00 | 11,419 | 0 | 60,024 | 48.6 K to 60 K (+23.49 %) |
Aug 16 2019 | NXGN | NEXTGEN HEALTHCARE ... | Barbarosh Craig A. | Director | Grant | A | 0.00 | 14,187 | 0 | 85,240 | 71.1 K to 85.2 K (+19.97 %) |
Jun 17 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Sell | S | 19.07 | 20,000 | 381,400 | 10,138,934 | 10.2 M to 10.1 M (-0.20 %) |
Jun 17 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Sell | S | 19.07 | 1,900 | 36,233 | 10,158,934 | 10.2 M to 10.2 M (-0.02 %) |
Jun 17 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Sell | S | 19.07 | 20,000 | 381,400 | 10,138,934 | 10.2 M to 10.1 M (-0.20 %) |
Jun 17 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Sell | S | 19.07 | 1,900 | 36,233 | 10,158,934 | 10.2 M to 10.2 M (-0.02 %) |
Jun 13 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Sell | S | 19.06 | 4,018 | 76,583 | 10,160,834 | 10.2 M to 10.2 M (-0.04 %) |
Jun 10 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Sell | S | 19.10 | 22,568 | 431,049 | 10,164,852 | 10.2 M to 10.2 M (-0.22 %) |
Jun 10 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Sell | S | 19.10 | 22,568 | 431,049 | 10,164,852 | 10.2 M to 10.2 M (-0.22 %) |
Jun 06 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Sell | S | 19.03 | 1,113 | 21,180 | 10,187,420 | 10.2 M to 10.2 M (-0.01 %) |
Jun 05 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Gift | G | 0.00 | 25,000 | 0 | 10,188,533 | 10.2 M to 10.2 M (-0.24 %) |
Jun 05 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Sell | S | 19.40 | 12,301 | 238,639 | 10,213,533 | 10.2 M to 10.2 M (-0.12 %) |
Jun 05 2019 | NXGN | NEXTGEN HEALTHCARE ... | RAZIN SHELDON | Director | Sell | S | 19.05 | 20,000 | 381,000 | 10,225,834 | 10.2 M to 10.2 M (-0.20 %) |
Jun 04 2019 | NXGN | NEXTGEN HEALTHCARE ... | Bristol George H | Director | Sell | S | 19.24 | 4,873 | 93,757 | 48,605 | 53.5 K to 48.6 K (-9.11 %) |
Jun 04 2019 | NXGN | NEXTGEN HEALTHCARE ... | Bristol George H | Director | Sell | S | 19.29 | 5,000 | 96,450 | 53,478 | 58.5 K to 53.5 K (-8.55 %) |
Jun 04 2019 | NXGN | NEXTGEN HEALTHCARE ... | Bristol George H | Director | Sell | S | 19.20 | 4,000 | 76,800 | 58,478 | 62.5 K to 58.5 K (-6.40 %) |
Apr 25 2019 | QSII | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 17.28 | 12,001 | 207,377 | 279,937 | 291.9 K to 279.9 K (-4.11 %) |
Jan 02 2019 | QSII | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Payment of Exercise | F | 15.15 | 7,326 | 110,989 | 291,938 | 299.3 K to 291.9 K (-2.45 %) |
Jan 02 2019 | QSII | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Payment of Exercise | F | 15.15 | 4,466 | 67,660 | 75,347 | 79.8 K to 75.3 K (-5.60 %) |
Oct 25 2018 | QSII | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Option Exercise | A | 0.00 | 33,600 | 0 | 33,600 | |
Oct 25 2018 | QSII | NEXTGEN HEALTHCARE ... | Metcalfe David A | Chief Technology Of ... | Grant | A | 0.00 | 33,000 | 0 | 79,813 | 46.8 K to 79.8 K (+70.49 %) |
Oct 25 2018 | QSII | NEXTGEN HEALTHCARE ... | LINTON JEFFREY D | EVP, General Counse ... | Option Exercise | A | 0.00 | 20,400 | 0 | 20,400 | |
Oct 25 2018 | QSII | NEXTGEN HEALTHCARE ... | LINTON JEFFREY D | EVP, General Counse ... | Grant | A | 0.00 | 20,000 | 0 | 20,323 | 323 to 20.3 K (+6,191.95 %) |
Oct 25 2018 | QSII | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Option Exercise | A | 0.00 | 101,600 | 0 | 101,600 | |
Oct 25 2018 | QSII | NEXTGEN HEALTHCARE ... | Frantz John R | CEO and President | Grant | A | 0.00 | 190,000 | 0 | 299,264 | 109.3 K to 299.3 K (+173.89 %) |
Oct 25 2018 | QSII | NEXTGEN HEALTHCARE ... | Arnold James Robert Jr. | Chief Financial Off ... | Option Exercise | A | 0.00 | 43,700 | 0 | 43,700 | |
Oct 25 2018 | QSII | NEXTGEN HEALTHCARE ... | Arnold James Robert Jr. | Chief Financial Off ... | Grant | A | 0.00 | 43,000 | 0 | 256,892 | 213.9 K to 256.9 K (+20.10 %) |
Aug 15 2018 | QSII | QUALITY SYSTEMS, I ... | PANNER MORRIS | Director | Grant | A | 0.00 | 6,631 | 0 | 45,759 | 39.1 K to 45.8 K (+16.95 %) |
Aug 15 2018 | QSII | QUALITY SYSTEMS, I ... | Rosenzweig Lance | Director | Grant | A | 0.00 | 6,631 | 0 | 49,677 | 43 K to 49.7 K (+15.40 %) |
Aug 15 2018 | QSII | QUALITY SYSTEMS, I ... | Klapstein Julie D | Director | Grant | A | 0.00 | 6,631 | 0 | 15,820 | 9.2 K to 15.8 K (+72.16 %) |
Aug 15 2018 | QSII | QUALITY SYSTEMS, I ... | MALONE JAMES C | Director | Grant | A | 0.00 | 6,631 | 0 | 47,234 | 40.6 K to 47.2 K (+16.33 %) |
Aug 15 2018 | QSII | QUALITY SYSTEMS, I ... | MARGOLIS JEFFREY H | Director | Grant | A | 0.00 | 8,460 | 0 | 71,917 | 63.5 K to 71.9 K (+13.33 %) |
Aug 15 2018 | QSII | QUALITY SYSTEMS, I ... | Bristol George H | Director | Grant | A | 0.00 | 6,631 | 0 | 62,478 | 55.8 K to 62.5 K (+11.87 %) |
Aug 15 2018 | QSII | QUALITY SYSTEMS, I ... | Barbarosh Craig A. | Director | Grant | A | 0.00 | 8,460 | 0 | 71,053 | 62.6 K to 71.1 K (+13.52 %) |
Aug 15 2018 | QSII | QUALITY SYSTEMS, I ... | RAZIN SHELDON | Director | Grant | A | 0.00 | 8,460 | 0 | 10,245,834 | 10.2 M to 10.2 M (+0.08 %) |
Jul 02 2018 | QSII | QUALITY SYSTEMS, I ... | Frantz John R | CEO and President | Payment of Exercise | F | 19.69 | 2,580 | 50,800 | 109,264 | 111.8 K to 109.3 K (-2.31 %) |
Mar 15 2018 | QSII | QUALITY SYSTEMS, I ... | Arnold James Robert Jr. | Chief Financial Off ... | Buy | P | 13.10 | 40,000 | 524,000 | 212,156 | 172.2 K to 212.2 K (+23.23 %) |
Mar 15 2018 | QSII | QUALITY SYSTEMS, I ... | RAZIN SHELDON | Director | Gift | G | 0.00 | 10,000 | 0 | 10,237,374 | 10.2 M to 10.2 M (-0.10 %) |
Jan 02 2018 | QSII | QUALITY SYSTEMS, I ... | Frantz John R | CEO and President | Payment of Exercise | F | 13.71 | 9,394 | 128,792 | 111,844 | 121.2 K to 111.8 K (-7.75 %) |
Jan 02 2018 | QSII | QUALITY SYSTEMS, I ... | Bostick Scott E | Chief Operating Off ... | Payment of Exercise | F | 13.71 | 4,853 | 66,535 | 46,813 | 51.7 K to 46.8 K (-9.39 %) |
Jan 02 2018 | QSII | QUALITY SYSTEMS, I ... | Metcalfe David A | Chief Technology Of ... | Payment of Exercise | F | 13.71 | 4,853 | 66,535 | 46,813 | 51.7 K to 46.8 K (-9.39 %) |
Nov 01 2017 | QSII | QUALITY SYSTEMS, I ... | Bostick Scott E | Chief Operating Off ... | Option Exercise | A | 14.07 | 140,000 | 1,970,038 | 140,000 | |
Nov 01 2017 | QSII | QUALITY SYSTEMS, I ... | Frantz John R | CEO and President | Option Exercise | A | 14.07 | 460,000 | 6,472,982 | 460,000 | |
Nov 01 2017 | QSII | QUALITY SYSTEMS, I ... | Arnold James Robert Jr. | Chief Financial Off ... | Option Exercise | A | 14.07 | 175,000 | 2,462,548 | 175,000 | |
Nov 01 2017 | QSII | QUALITY SYSTEMS, I ... | Metcalfe David A | Chief Technology Of ... | Option Exercise | A | 14.07 | 140,000 | 1,970,038 | 140,000 | |
Aug 23 2017 | QSII | QUALITY SYSTEMS, I ... | Barbarosh Craig A. | Director | Grant | A | 0.00 | 11,724 | 0 | 62,593 | 50.9 K to 62.6 K (+23.05 %) |
Aug 23 2017 | QSII | QUALITY SYSTEMS, I ... | Bristol George H | Director | Grant | A | 0.00 | 9,189 | 0 | 55,847 | 46.7 K to 55.8 K (+19.69 %) |
Aug 23 2017 | QSII | QUALITY SYSTEMS, I ... | Klapstein Julie D | Director | Grant | A | 0.00 | 9,189 | 0 | 9,189 | 0 to 9.2 K |
Aug 23 2017 | QSII | QUALITY SYSTEMS, I ... | PANNER MORRIS | Director | Grant | A | 0.00 | 9,189 | 0 | 39,128 | 29.9 K to 39.1 K (+30.69 %) |
Aug 23 2017 | QSII | QUALITY SYSTEMS, I ... | RAZIN SHELDON | Director | Grant | A | 0.00 | 11,724 | 0 | 10,247,374 | 10.2 M to 10.2 M (+0.11 %) |
Aug 23 2017 | QSII | QUALITY SYSTEMS, I ... | Rosenzweig Lance | Director | Grant | A | 0.00 | 9,189 | 0 | 43,046 | 33.9 K to 43 K (+27.14 %) |
Aug 23 2017 | QSII | QUALITY SYSTEMS, I ... | MARGOLIS JEFFREY H | Director | Grant | A | 0.00 | 11,724 | 0 | 63,457 | 51.7 K to 63.5 K (+22.66 %) |
Aug 23 2017 | QSII | QUALITY SYSTEMS, I ... | MALONE JAMES C | Director | Grant | A | 0.00 | 9,189 | 0 | 40,603 | 31.4 K to 40.6 K (+29.25 %) |
Aug 22 2017 | QSII | QUALITY SYSTEMS, I ... | Pflueger Russell | Director | Sell | S | 15.73 | 17,568 | 276,345 | 29,177 | 46.7 K to 29.2 K (-37.58 %) |
Aug 22 2017 | QSII | QUALITY SYSTEMS, I ... | Pflueger Russell | Director | Sell | S | 15.87 | 3,400 | 53,958 | 46,745 | 50.1 K to 46.7 K (-6.78 %) |
Jan 03 2017 | QSII | QUALITY SYSTEMS, I ... | Arnold James Robert Jr. | EVP, Chief Financia ... | Grant | A | 0.00 | 28,000 | 0 | 170,265 | 142.3 K to 170.3 K (+19.68 %) |
Jan 03 2017 | QSII | QUALITY SYSTEMS, I ... | Arnold James Robert Jr. | EVP, Chief Financia ... | Grant | A | 0.00 | 52,000 | 0 | 142,265 | 90.3 K to 142.3 K (+57.61 %) |
Jan 03 2017 | QSII | QUALITY SYSTEMS, I ... | Frantz John R | CEO and President | Grant | A | 0.00 | 35,000 | 0 | 124,369 | 89.4 K to 124.4 K (+39.16 %) |
Jan 03 2017 | QSII | QUALITY SYSTEMS, I ... | Frantz John R | CEO and President | Grant | A | 0.00 | 65,000 | 0 | 89,369 | 24.4 K to 89.4 K (+266.73 %) |
Jan 03 2017 | QSII | QUALITY SYSTEMS, I ... | MOREFIELD DANIEL | EVP, Chief Operatin ... | Grant | A | 0.00 | 4,083 | 0 | 21,859 | 17.8 K to 21.9 K (+22.97 %) |
Jan 03 2017 | QSII | QUALITY SYSTEMS, I ... | MOREFIELD DANIEL | EVP, Chief Operatin ... | Grant | A | 0.00 | 7,583 | 0 | 17,776 | 10.2 K to 17.8 K (+74.39 %) |
Jan 03 2017 | QSII | QUALITY SYSTEMS, I ... | Metcalfe David A | EVP, Chief Technolo ... | Grant | A | 0.00 | 18,083 | 0 | 51,666 | 33.6 K to 51.7 K (+53.85 %) |
Jan 03 2017 | QSII | QUALITY SYSTEMS, I ... | Metcalfe David A | EVP, Chief Technolo ... | Grant | A | 0.00 | 33,583 | 0 | 33,583 | 0 to 33.6 K |
Jan 03 2017 | QSII | QUALITY SYSTEMS, I ... | STUMPF JOHN K | EVP, Principal Acct ... | Grant | A | 0.00 | 4,083 | 0 | 14,887 | 10.8 K to 14.9 K (+37.79 %) |